Anupam Rama Analyst PerformanceAnalyst at JPMorgan Chase & Co.Anupam Rama is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 42 publicly traded companies. Over the past year, Anupam Rama has issued 72 stock ratings, including buy, hold, and sell recommendations. While full access to Anupam Rama's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anupam Rama's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings131 Last 10 YearsBuy Recommendations81.68% 107 Buy RatingsCompanies Covered42 Unique Companies Ratings Distribution131RatingsDistribution of strong buy, buy, hold, and sell ratings by Anupam Rama.RatingPercentageCount Strong Buy0.0%0 ratings Buy81.7%107 ratings Hold14.5%19 ratings Sell3.8%5 ratingsOut of 131 total stock ratings issued by Anupam Rama at JPMorgan Chase & Co., the majority (81.7%) have been Buy recommendations, followed by 14.5% Hold and 3.8% Sell.Best & Worst CallsBest Call0000.0%MAZEFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%PTGXOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ42 companiesAnupam Rama, an analyst at JPMorgan Chase & Co., currently covers 42 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical39 companies92.9%Manufacturing2 companies4.8%Energy1 company2.4%Anupam Rama of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Energy companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE33 companies78.6%MED - DRUGS4 companies9.5%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2 companies4.8%BIOTECHNOLOGY1 company2.4%MED - GENERIC DRG1 company2.4%SOLAR1 company2.4% Anupam Rama's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNBIXNeurocrine Biosciences5/8/2026Boost Price Target$152.28$185.00Overweight$0.0000.00% ROITRAXFirst Tracks Biotherapeutics4/23/2026Initiated Coverage$18.87$31.00Overweight$0.0000.00% ROIREPLReplimune Group4/13/2026Reiterated Rating$4.77Underweight$0.0000.00% ROIAPLSApellis Pharmaceuticals4/1/2026Reiterated Rating$40.39$41.00Neutral$0.0000.00% ROIMAZEMaze Therapeutics3/31/2026Boost Price Target$30.20$58.00Overweight$0.0000.00% ROITVTXTravere Therapeutics3/25/2026Lower Price Target$27.14$41.00Overweight$0.0000.00% ROISLDBSolid Biosciences3/25/2026Boost Price Target$7.28$12.00Overweight$0.0000.00% ROIOLMAOlema Pharmaceuticals3/18/2026Boost Price Target$14.45$58.00Overweight$0.0000.00% ROIERASErasca3/18/2026Boost Price Target$13.51$25.00Overweight$0.0000.00% ROIZLABZai Lab3/18/2026Lower Price Target$18.92$32.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CTMXCytomX Therapeutics3/16/2026Upgrade$7.86$12.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences3/12/2026Boost Price Target$128.49$177.00Overweight$0.0000.00% ROIRAREUltragenyx Pharmaceutical3/12/2026Lower Price Target$21.44$74.00Overweight$0.0000.00% ROIDAWNDay One Biopharmaceuticals3/11/2026Reiterated Rating$21.31$21.50Neutral$0.0000.00% ROIBBIOBridgeBio Pharma3/10/2026Boost Price Target$74.18$94.00Overweight$0.0000.00% ROISNDXSyndax Pharmaceuticals3/9/2026Boost Price Target$24.74$45.00Overweight$0.0000.00% ROIAPLSApellis Pharmaceuticals3/5/2026Boost Price Target$20.15$37.00Overweight$0.0000.00% ROIAGMBAgomAb Therapeutics3/3/2026Initiated Coverage$16.21$32.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences2/17/2026Lower Price Target$128.66$176.00Overweight$0.0000.00% ROIZLABZai Lab2/5/2026Lower Price Target$17.25$39.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences1/12/2026Lower Price Target$132.91$177.00Overweight$0.0000.00% ROIVERAVera Therapeutics12/19/2025Lower Price Target$50.24$96.00Overweight$0.0000.00% ROICOGTCogent Biosciences12/19/2025Boost Price Target$38.89$67.00Overweight$0.0000.00% ROIVORVor Biopharma12/19/2025Lower Price Target$12.84$40.00Overweight$0.0000.00% ROINUVLNuvalent12/19/2025Lower Price Target$103.23$145.00Overweight$0.0000.00% ROIVORVor Biopharma12/9/2025Initiated Coverage$8.36$43.00Overweight$0.0000.00% ROINVAXNovavax11/18/2025Lower Price Target$6.56$6.00Underweight$0.0000.00% ROIORICOric Pharmaceuticals11/18/2025Boost Price Target$11.70$20.00Overweight$0.0000.00% ROIOLMAOlema Pharmaceuticals11/18/2025Boost Price Target$21.48$32.00Overweight$0.0000.00% ROICDTXCidara Therapeutics11/17/2025Downgrade$217.78Neutral$0.0000.00% ROIENTAEnanta Pharmaceuticals11/14/2025Initiated Coverage$11.72$17.00Overweight$0.0000.00% ROISNDXSyndax Pharmaceuticals11/12/2025Lower Price Target$16.78$33.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics11/12/2025Boost Price Target$29.58$57.00Overweight$0.0000.00% ROIDAWNDay One Biopharmaceuticals11/7/2025Boost Price Target$9.74$27.00Overweight$0.0000.00% ROIBBIOBridgeBio Pharma11/7/2025Boost Price Target$62.11$77.00Overweight$0.0000.00% ROIVERAVera Therapeutics11/7/2025Lower Price Target$24.17$52.00Overweight$0.0000.00% ROIFOLDAmicus Therapeutics11/6/2025Boost Price Target$8.90$19.00Overweight$0.0000.00% ROIAPLSApellis Pharmaceuticals11/5/2025Lower Price Target$20.02$36.00Overweight$0.0000.00% ROISLDBSolid Biosciences11/5/2025Lower Price Target$3.96$11.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences11/3/2025Boost Price Target$140.28$179.00Overweight$0.0000.00% ROIMillionaire warns: Move your money now (Ad)Larry Benedict, the hedge fund trader who generated $274 million in profits for clients and beat the S&P 500 by 18 times in 2025, says Trump's installation of a new Federal Reserve chair is triggering the most significant shift in U.S. markets in nearly 20 years. Benedict's track record around Fed moves is hard to ignore - 62% from a single position after 2020 rate cuts, 117% in under a month when rate hikes were signaled in 2022, and an 89% gain in 17 days following a Jackson Hole speech. He has already identified the one ticker he believes will be at the center of the coming money flows, and he's sharing it free.Click here to see the ticker Larry Benedict is recommending right nowKODKodiak Sciences10/24/2025Upgrade$17.11$24.00Overweight$0.0000.00% ROIIDYAIDEAYA Biosciences10/23/2025Boost Price Target$28.58$79.00Overweight$0.0000.00% ROICOGTCogent Biosciences10/21/2025Boost Price Target$16.22$44.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics10/20/2025Upgrade$36.85$55.00Overweight$0.0000.00% ROIREPLReplimune Group10/20/2025Upgrade$8.93$11.00Neutral$0.0000.00% ROICDTXCidara Therapeutics10/10/2025Initiated Coverage$110.76$200.00Overweight$0.0000.00% ROIMAZEMaze Therapeutics9/29/2025Boost Price Target$27.00$37.00Overweight$0.0000.00% ROIREPLReplimune Group9/19/2025Reiterated Rating$3.46Underweight$0.0000.00% ROICAMPCAMP4 Therapeutics9/16/2025Downgrade$2.74Neutral$0.0000.00% ROIBBIOBridgeBio Pharma9/3/2025Boost Price Target$52.20$70.00Overweight$0.0000.00% ROIIDYAIDEAYA Biosciences9/3/2025Boost Price Target$25.93$74.00Overweight$0.0000.00% ROIKODKodiak Sciences8/14/2025Upgrade$8.62$15.00Neutral$0.0000.00% ROISLDBSolid Biosciences8/14/2025Lower Price Target$6.27$13.00Overweight$0.0000.00% ROIORICOric Pharmaceuticals8/14/2025Lower Price Target$9.71$17.00Overweight$0.0000.00% ROIOLMAOlema Pharmaceuticals8/14/2025Boost Price Target$5.24$29.00Overweight$0.0000.00% ROICOGTCogent Biosciences8/7/2025Boost Price Target$10.79$30.00Overweight$0.0000.00% ROIVERAVera Therapeutics8/7/2025Lower Price Target$19.72$53.00Overweight$0.0000.00% ROIAPLSApellis Pharmaceuticals8/4/2025Boost Price Target$24.26$37.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences7/31/2025Boost Price Target$128.23$145.00Neutral$0.0000.00% ROIRAPTRapt Therapeutics7/30/2025Upgrade$11.53$14.00Neutral$0.0000.00% ROISRPTSarepta Therapeutics7/29/2025Upgrade$13.86$24.00Neutral$0.0000.00% ROIIDYAIDEAYA Biosciences7/28/2025Boost Price Target$24.50$72.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics7/25/2025Reiterated Rating$12.89Underweight$0.0000.00% ROIANABAnaptysBio7/24/2025Boost Price Target$26.91$80.00Overweight$0.0000.00% ROIREPLReplimune Group7/22/2025Reiterated Rating$3.05$9.00Neutral$0.0000.00% ROISRPTSarepta Therapeutics7/21/2025Lower Price Target$14.07$20.00Overweight$0.0000.00% ROIREPLReplimune Group7/16/2025Boost Price Target$12.40$19.00Overweight$0.0000.00% ROICOGTCogent Biosciences7/10/2025Boost Price Target$11.02$29.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics7/10/2025Lower Price Target$19.01$28.00Overweight$0.0000.00% ROICOGTCogent Biosciences5/29/2025Boost Price Target$5.22$25.00Overweight$0.0000.00% ROIIDYAIDEAYA Biosciences5/22/2025Boost Price Target$19.04$66.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics5/20/2025Lower Price Target$37.68$84.00Overweight$0.0000.00% ROIOLMAOlema Pharmaceuticals3/28/2025Lower Price Target$4.20$28.00Overweight$00.0000.00% ROIRAREUltragenyx Pharmaceutical3/27/2025Boost Price Target$38.88$117.00Overweight$00.0000.00% ROINBIXNeurocrine Biosciences3/26/2025Boost Price Target$116.18$184.00Overweight$000.0000.00% ROIBBIOBridgeBio Pharma3/24/2025Boost Price Target$34.77$50.00Overweight$00.0000.00% ROISNDXSyndax Pharmaceuticals3/20/2025Boost Price Target$13.84$41.00Overweight$00.0000.00% ROIZLABZai Lab3/13/2025Boost Price Target$36.14$51.00Overweight$00.0000.00% ROISLDBSolid Biosciences3/13/2025Lower Price Target$5.15$11.00Overweight$0.0000.00% ROIANABAnaptysBio3/5/2025Boost Price Target$15.19$42.00Overweight$00.0000.00% ROIDAWNDay One Biopharmaceuticals3/5/2025Lower Price Target$9.32$34.00Overweight$00.0000.00% ROISNDXSyndax Pharmaceuticals3/4/2025Boost Price Target$14.46$39.00Overweight$00.0000.00% ROIAPLSApellis Pharmaceuticals3/4/2025Boost Price Target$24.65$54.00Overweight$00.0000.00% ROIVERAVera Therapeutics3/4/2025Lower Price Target$28.66$71.00Overweight$00.0000.00% ROITVTXTravere Therapeutics2/26/2025Boost Price Target$21.45$44.00Overweight$00.0000.00% ROIREPLReplimune Group2/26/2025Boost Price Target$13.60$18.00Overweight$0.0000.00% ROIORICOric Pharmaceuticals2/26/2025Boost Price Target$8.69$22.00Overweight$00.0000.00% ROIMAZEMaze Therapeutics2/25/2025Initiated Coverage$10.82$30.00Overweight$00.0000.00% ROIORICOric Pharmaceuticals2/6/2025Boost Price Target$12.72$21.00Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaJPMorgan Chase & Co.Berenberg BankWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
